John P. Roberts, MD, FACS

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
John P. Roberts, MD, FACS

Professor, Department of Surgery, and Chief, Division of Transplantation, UCSF

Phone: (415) 353-1888 (appts)
Box 0780, UCSF
San Francisco, CA 94143-0780

View on UCSF Profiles

Cancer Center Membership

Associate Member » Non-aligned

Education

Stanford University, Palo Alto, CA, BS, 1976, Biology
University of California, San Diego, CA, MD, 1980, Medicine
University of Washington, Seattle, Surgery Resident, 1980-83
Cornell University, New York, Research Fellow, 1983-85
University of Washington, Seattle, Surgery Resident, 1985-86
University of Minnesota, Minneapolis, Transplant Fellow, 1986-87


Professional Experience

  • 1988-1993
    University of California San Francisco, Assistant Professor
  • 1993-1997
    University of California San Francisco, Associate Professor
  • 1995-present
    California Pacific Medical Center, San Francisco, Surgical Director, Liver Transplant Department
  • 1997-present
    University of California San Francisco, Professor
  • 1999-present
    University of California San Francisco, Chief, Transplant Service

Honors & Awards

  • 1991
    Chief Resident Teaching Award, Department of Surgery, UCSF
  • 1992
    Chief Resident Teaching Award, Department of Surgery, UCSF

Selected Publications

  1. Olmos A, Feiner J, Hirose R, Swain S, Blasi A, Roberts JP, Niemann CU. Impact of a quality improvement project on deceased organ donor management. Prog Transplant. 2015 Dec; 25(4):351-60.
    View on PubMed
  2. Kwong AJ, Lai JC, Dodge JL, Roberts JP. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score. Liver Transpl. 2015 Nov; 21(11):1403-9.
    View on PubMed
  3. Roberts JP. Transplantation: Allocation of liver transplants-a road to consensus. Nat Rev Gastroenterol Hepatol. 2015 Nov; 12(11):615-6.
    View on PubMed
  4. Axelrod DA, Vagefi PA, Roberts JP. The Evolution of Organ Allocation for Liver Transplantation: Tackling Geographic Disparity Through Broader Sharing. Ann Surg. 2015 Aug; 262(2):224-7.
    View on PubMed
  5. Niemann CU, Feiner J, Swain S, Bunting S, Friedman M, Crutchfield M, Broglio K, Hirose R, Roberts JP, Malinoski D. Therapeutic Hypothermia in Deceased Organ Donors and Kidney-Graft Function. N Engl J Med. 2015 Jul 30; 373(5):405-14.
    View on PubMed
  6. Macdonald B, Sewell JL, Harper AM, Roberts JP, Yao FY. Liver transplantation for hepatocellular carcinoma: analysis of factors predicting outcome in 1074 patients in OPTN Region 5. Clin Transplant. 2015 Jun; 29(6):506-12.
    View on PubMed
  7. Yao FY, Mehta N, Flemming J, Dodge J, Hameed B, Fix O, Hirose R, Fidelman N, Kerlan RK, Roberts JP. Downstaging of hepatocellular cancer before liver transplant: Long-term outcome compared to tumors within Milan criteria. Hepatology. 2015 Jun; 61(6):1968-77.
    View on PubMed
  8. Lai JC, Covinsky KE, Hayssen H, Lizaola B, Dodge JL, Roberts JP, Terrault NA, Feng S. Clinician assessments of health status predict mortality in patients with end-stage liver disease awaiting liver transplantation. Liver Int. 2015 Sep; 35(9):2167-73.
    View on PubMed
  9. Samoylova ML, Dodge JL, Mehta N, Yao FY, Roberts JP. Evaluating the validity of model for end-stage liver disease exception points for hepatocellular carcinoma patients with multiple nodules <2 cm. Clin Transplant. 2015 Jan; 29(1):52-9.
    View on PubMed
  10. Roberts JP. Does center-specific reporting limit innovation. Liver Transpl. 2014 Nov; 20 Suppl 2:S42-4.
    View on PubMed
  11. Feng K, Gupta V, Terrazas E, Yeghiazarians Y, Ports T, Gregoratos G, Tavakol M, Roberts JP, Boyle A. Trans-radial versus trans-femoral access in patients with end-stage liver disease undergoing cardiac catheterization. Am J Cardiovasc Dis. 2014; 4(3):133-9.
    View on PubMed
  12. Yao FY, Hameed B, Mehta N, Roberts JP. Response to letter to the editors. Liver Transpl. 2014 Oct; 20(10):1285.
    View on PubMed
  13. Hameed B, Mehta N, Sapisochin G, Roberts JP, Yao FY. Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria. Liver Transpl. 2014 Aug; 20(8):945-51.
    View on PubMed
  14. Samoylova ML, Dodge JL, Yao FY, Roberts JP. Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation. Liver Transpl. 2014 Aug; 20(8):937-44.
    View on PubMed
  15. Mehta N, Dodge JL, Roberts JP, Hirose R, Yao FY. Outcomes after liver transplantation for patients with hepatocellular carcinoma and a low risk of dropout from the transplant waiting list. Liver Transpl. 2014 May; 20(5):627-8.
    View on PubMed
  16. Lai JC, Kahn JG, Roberts JP. Author response: reducing infection transmission in solid organ transplantation through donor nucleic acid testing: a cost-effectiveness analysis. Am J Transplant. 2014 Apr; 14(4):981.
    View on PubMed
  17. Roll GR, Roberts JP. Left versus right lobe liver donation. Am J Transplant. 2014 Feb; 14(2):251-2.
    View on PubMed
  18. Mehta N, Dodge JL, Goel A, Roberts JP, Hirose R, Yao FY. Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: implications for the current organ allocation policy. Liver Transpl. 2013 Dec; 19(12):1343-53.
    View on PubMed
  19. Perito ER, Rhee S, Roberts JP, Rosenthal P. Pediatric liver transplantation for urea cycle disorders and organic acidemias: United Network for Organ Sharing data for 2002-2012. Liver Transpl. 2014 Jan; 20(1):89-99.
    View on PubMed
  20. Neidich E, Neidich AB, Axelrod DA, Roberts JP. Consumerist responses to scarcity of organs for transplant. Virtual Mentor. 2013 Nov; 15(11):966-72.
    View on PubMed

Go to UCSF Profiles, powered by CTSI